CKD-385
Sponsors
Chong Kun Dang Pharmaceutical
Conditions
Cardiovascular Diseases
Phase 1
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT04906785
Start: 2021-06-04End: 2021-08-06Target: 52Updated: 2021-05-28
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
NCT04906798
Start: 2021-06-04End: 2021-07-23Target: 52Updated: 2021-05-28